Concord Biotech has announced a final dividend of Rs. 10.70 per share, pending shareholder approval at the AGM. This generous payout highlights the company’s strong profitability, backed by a consolidated net profit of Rs. 371.64 Cr and earnings per share of Rs. 35.52. The dividend underscores healthy cash flow and solid financial strength, providing shareholders with an attractive return.